Skip to main content
. 2018 Dec 14;9(98):37097–37111. doi: 10.18632/oncotarget.26365

Figure 3. TAGLN2 mRNA levels are associated with poor survival among gliomas.

Figure 3

(A) TAGLN2 mRNA levels above the median (detected by Affymetrix Clariom D array) trended toward poor OS in lower grade gliomas from our institutional cohort (HR 3.74, p=0.079), as shown by the Kaplan Meier curve. (B) In the TCGA validation dataset, high TAGLN2 mRNA levels above the median were significantly associated with poor survival (HR= 2.6, p=0.00003).